This inventor holds 2 USPTO granted patents. Top assignee: Tel Aviv University. Active years: 2011-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2012
Title: Yariv Mazor: Innovator in Immunotoxin Production
Introduction
Yariv Mazor is a notable inventor based in Raanana, Israel. He has made significant contributions to the field of immunotoxin production, holding 2 patents that showcase his innovative work. His research focuses on developing fusion proteins that can enhance targeted cell killing, which has important implications in medical treatments.
Latest Patents
Mazor's latest patents include a recombinant fusion protein and polynucleotide construct for immunotoxin production. This invention relates to a polynucleotide construct encoding a fusion protein that consists of a domain binding the immunoglobulin Fc region, genetically fused to a truncated form of exotoxin A (PE). Specifically, the invention discloses the fusion protein ZZ-PE38 and provides immunotoxins formed from complexes of the fusion protein with antibodies for targeted cell killing.
Career Highlights
Yariv Mazor is affiliated with Tel Aviv University, where he continues to advance his research in immunology and biotechnology. His work has garnered attention for its potential applications in cancer therapy and other medical fields.
Collaborations
Mazor collaborates with Itai Benhar, a fellow researcher, to further explore the applications of his inventions in the medical field.
Conclusion
Yariv Mazor's contributions to immunotoxin production through his innovative patents highlight his role as a key figure in advancing medical research. His work continues to pave the way for new therapeutic approaches.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile